↓ Skip to main content

The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells

Overview of attention for article published in Breast Cancer Research and Treatment, November 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
38 Mendeley
Title
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells
Published in
Breast Cancer Research and Treatment, November 2010
DOI 10.1007/s10549-010-1232-1
Pubmed ID
Authors

Caroline Brünner-Kubath, Waheed Shabbir, Victoria Saferding, Renate Wagner, Christian F. Singer, Peter Valent, Walter Berger, Brigitte Marian, Christoph C. Zielinski, Michael Grusch, Thomas W. Grunt

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 37 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 29%
Researcher 5 13%
Other 4 11%
Professor > Associate Professor 4 11%
Student > Postgraduate 3 8%
Other 6 16%
Unknown 5 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 32%
Medicine and Dentistry 11 29%
Biochemistry, Genetics and Molecular Biology 6 16%
Nursing and Health Professions 1 3%
Veterinary Science and Veterinary Medicine 1 3%
Other 2 5%
Unknown 5 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2015.
All research outputs
#7,536,586
of 22,994,508 outputs
Outputs from Breast Cancer Research and Treatment
#1,674
of 4,677 outputs
Outputs of similar age
#36,250
of 101,005 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#23
of 42 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,677 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 101,005 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.